Avintol ® is a preparation of vinpocetine which increases cerebral metabolism by increasing glucose and oxygen utilization, improves cerebral microcirculation by inhibiting platelet aggregation,decreasing blood viscosity and promoting oxygen transport. It selectively and intensely increases cerebral blood flow and the share of the brain in the cardiac output, it reduces cerebral vascular resistance without affecting systemic circulation (blood pressure, heart rate, cardiac output, total peripheral resistance).
No Data
Avintol ® is indicated for the treatment of –
Initial dose
The recommended initial dose is one to two tablets thrice daily with meals.
Maintenance dose
The recommended maintenance dose is one tablet thrice daily over long periods.
Vinpocetine should not be used in pregnancy and lactation.
Vinpocetine should be avoided in patients with probability of bleeding due to its anticoagulation effect and should be taken with caution in patients with hypertension or cardiac dysfunction.
Avintol ® is contraindicated in patients with a hypersensitivity to vinpocetine or any of the exipients.
Vinpocetine should not be used with any anticoagulants such as warfarin and heparin.
No Data
Keep away from the reach of children. Store in a cool and dry place protected from light. To be taken and sold only on the prescription of a registered physician.